LandosBio

LandosBio

LandosBio

Landos pursues safer, more effective first-in-class oral therapeutics for autoimmune disorders at an accelerated rate.
Raised
$10M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$10,000,000
Venture capital (Series A) - 2017
Perceptive Advisors
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when LandosBio makes some noise.